Annika Christine Magnusson

Annika Christine Magnusson (board member) discloses dealings in Moberg Pharma AB (publ) to Finansinspektionen. The record holds 2 filings, for trades running from 5 June 2025 to 7 July 2026.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.

The latest filing, published on 7 July 2026, reports a share grant of €9,935 in Moberg Pharma AB (publ). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.